Cancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine.
Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options. A recent research study led by Karin Schelch and Michael Grusch from MedUni Vienna identified ...
Oct 11, 2023
0
2
Colon cancers that spread to the liver may be substantially different depending on the location where cancerous cells originate, according to new research. The study led by Yale Cancer Center researchers at Yale School of ...
Sep 20, 2023
0
36
Combining a cancer-targeting virus with radiation to treat brain cancer in mice was more effective than either therapy on its own according to new research, providing hope for new treatments that combine immunotherapy with ...
Jun 14, 2023
0
79
Recent findings in the laboratory of University of Kentucky Markey Cancer Center researcher Christine Brainson, Ph.D., could lead to promising treatments for two molecular subtypes of lung cancer.
Feb 10, 2022
0
11
Cancer cells show unchecked rapid growth beyond tissue boundaries that is no longer stopped by normal control mechanisms. Due to this rapid growth, the metabolism of cancer cells is altered compared to that of cells that ...
Dec 17, 2021
0
2
Three-dimensional (3D) culturing approaches help probe cancer stem-like cells (CSCs)-associated traits, chemoresistance, and cellular heterogeneity ex vivo. For instance, the culture of organoid-driven clinical cancer specimens ...
Oct 7, 2021
0
14
Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of pediatric brain cancer.
May 20, 2021
0
7
A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer. A multi-institution study led by UC Davis Comprehensive Cancer Center researchers found that targeting androgen ...
Apr 28, 2021
0
13
Head and neck cancer is the sixth most common cancer worldwide, and while effective treatments exist, sadly, the cancer often returns.
Jan 23, 2021
0
46
Rhabdomyosarcoma is the most common childhood cancer in the soft tissues, and it mainly originates in the muscles. It represents almost 5% of pediatric tumors, and the survival rate is between 60% and 70%. The work published ...
Jan 29, 2020
0
3
